Quarterly report · Q1

Period2022-12-01 → 2023-02-28
Filed2023-04-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥12.8bn2022-12-01 → 2023-02-28Cons.Net sales
Revenue¥49.6bn2021-12-01 → 2022-11-30Cons.Net sales (5-year summary)
Revenue¥12.3bn2021-12-01 → 2022-02-28Cons.Net sales
Operating income−¥92m2022-12-01 → 2023-02-28Cons.Operating income
Operating income¥630m2021-12-01 → 2022-02-28Cons.Operating income
Ordinary income−¥63m2022-12-01 → 2023-02-28Cons.Ordinary income
Ordinary income¥887m2021-12-01 → 2022-11-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥660m2021-12-01 → 2022-02-28Cons.Ordinary income
Profit before tax−¥85m2022-12-01 → 2023-02-28Cons.Income before income taxes
Profit before tax¥659m2021-12-01 → 2022-02-28Cons.Income before income taxes
Net income (owners)−¥206m2022-12-01 → 2023-02-28Cons.Profit loss attributable to owners of parent
Net income (owners)¥580m2021-12-01 → 2022-11-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥449m2021-12-01 → 2022-02-28Cons.Profit loss attributable to owners of parent
Net income−¥208m2022-12-01 → 2023-02-28Cons.Profit loss
Net income¥449m2021-12-01 → 2022-02-28Cons.Profit loss
Total assets¥63.6bnat 2023-02-28Cons.Assets
Total assets¥63.6bnat 2022-11-30Cons.Assets
Total assets¥63.1bnat 2022-02-28Cons.Total assets (5-year summary)
Total liabilities¥37.1bnat 2023-02-28Cons.Liabilities
Total liabilities¥36.5bnat 2022-11-30Cons.Liabilities
Net assets / equity¥26.5bnat 2023-02-28Cons.Net assets
Net assets / equity¥27.1bnat 2022-11-30Cons.Net assets
Net assets / equity¥27.4bnat 2022-02-28Cons.Net assets (5-year summary)
Cash and deposits¥6.8bnat 2023-02-28Cons.Cash and deposits
Cash and deposits¥6.9bnat 2022-11-30Cons.Cash and deposits
EPS (basic)¥-5.242022-12-01 → 2023-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥14.562021-12-01 → 2022-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥11.262021-12-01 → 2022-02-28Cons.Basic earnings loss per share (5-year summary)
Equity ratio41.5%at 2023-02-28Cons.Equity to asset ratio (5-year summary)
Equity ratio42.5%at 2022-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio43.4%at 2022-02-28Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 59
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-12-01 → 2023-02-28¥1m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-12-01 → 2023-02-28¥1m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-12-01 → 2023-02-28¥55,000
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-12-01 → 2023-02-28−¥23m
Reconciling Itemsreconcilingrevenue2022-12-01 → 2023-02-28−¥430m
Reconciling Itemsreconcilingrevenue intersegment2022-12-01 → 2023-02-28−¥430m
Reconciling Itemsreconcilingsegment profit2022-12-01 → 2023-02-28¥60m
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentrevenue2022-12-01 → 2023-02-28¥4.0bn
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentrevenue external2022-12-01 → 2023-02-28¥3.6bn
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentrevenue intersegment2022-12-01 → 2023-02-28¥342m
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentsegment profit2022-12-01 → 2023-02-28−¥56m
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentrevenue2022-12-01 → 2023-02-28¥4.2bn
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentrevenue external2022-12-01 → 2023-02-28¥4.2bn
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentrevenue intersegment2022-12-01 → 2023-02-28¥10m
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentsegment profit2022-12-01 → 2023-02-28−¥41m
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentrevenue2022-12-01 → 2023-02-28¥2.0bn
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentrevenue external2022-12-01 → 2023-02-28¥2.0bn
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentrevenue intersegment2022-12-01 → 2023-02-28¥17m
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentsegment profit2022-12-01 → 2023-02-28−¥105m
jpcrp040300-q1r_E02585-000Medicalreportable segmentrevenue2022-12-01 → 2023-02-28¥3.0bn
jpcrp040300-q1r_E02585-000Medicalreportable segmentrevenue external2022-12-01 → 2023-02-28¥2.9bn
jpcrp040300-q1r_E02585-000Medicalreportable segmentrevenue intersegment2022-12-01 → 2023-02-28¥61m
jpcrp040300-q1r_E02585-000Medicalreportable segmentsegment profit2022-12-01 → 2023-02-28¥73m
—segment totalrevenue2022-12-01 → 2023-02-28¥13.2bn
—segment totalrevenue external2022-12-01 → 2023-02-28¥12.8bn
—segment totalrevenue intersegment2022-12-01 → 2023-02-28¥430m
—segment totalsegment profit2022-12-01 → 2023-02-28−¥129m
Total Of Reportable Segments And Otherssegment totalrevenue2022-12-01 → 2023-02-28¥13.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-12-01 → 2023-02-28¥12.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-12-01 → 2023-02-28¥430m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-12-01 → 2023-02-28−¥152m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-12-01 → 2022-02-28−¥9m
Reconciling Itemsreconcilingrevenue2021-12-01 → 2022-02-28−¥364m
Reconciling Itemsreconcilingrevenue intersegment2021-12-01 → 2022-02-28−¥364m
Reconciling Itemsreconcilingsegment profit2021-12-01 → 2022-02-28¥18m
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentrevenue2021-12-01 → 2022-02-28¥3.9bn
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentrevenue external2021-12-01 → 2022-02-28¥3.8bn
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentrevenue intersegment2021-12-01 → 2022-02-28¥162m
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentsegment profit2021-12-01 → 2022-02-28¥521m
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentrevenue2021-12-01 → 2022-02-28¥3.6bn
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentrevenue external2021-12-01 → 2022-02-28¥3.5bn
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentrevenue intersegment2021-12-01 → 2022-02-28¥47m
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentsegment profit2021-12-01 → 2022-02-28−¥96m
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentrevenue2021-12-01 → 2022-02-28¥2.3bn
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentrevenue external2021-12-01 → 2022-02-28¥2.2bn
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentrevenue intersegment2021-12-01 → 2022-02-28¥30m
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentsegment profit2021-12-01 → 2022-02-28¥41m
jpcrp040300-q1r_E02585-000Medicalreportable segmentrevenue2021-12-01 → 2022-02-28¥2.9bn
jpcrp040300-q1r_E02585-000Medicalreportable segmentrevenue external2021-12-01 → 2022-02-28¥2.7bn
jpcrp040300-q1r_E02585-000Medicalreportable segmentrevenue intersegment2021-12-01 → 2022-02-28¥124m
jpcrp040300-q1r_E02585-000Medicalreportable segmentsegment profit2021-12-01 → 2022-02-28¥156m
—segment totalrevenue2021-12-01 → 2022-02-28¥12.6bn
—segment totalrevenue external2021-12-01 → 2022-02-28¥12.3bn
—segment totalrevenue intersegment2021-12-01 → 2022-02-28¥364m
—segment totalsegment profit2021-12-01 → 2022-02-28¥621m
Total Of Reportable Segments And Otherssegment totalrevenue2021-12-01 → 2022-02-28¥12.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-12-01 → 2022-02-28¥12.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-12-01 → 2022-02-28¥364m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-12-01 → 2022-02-28¥612m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 439
ItemContextValueUnit
Independent auditors report consolidated (text)FilingDateInstantText · Plus
Audit firm1 consolidatedFilingDateInstant
Original text (Japanese)PwCあらた有限責任監査法人
Cpa1 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)五代  英紀
Cpa2 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)新田  將貴
Number of submissionFilingDateInstant1
Net sales (5-year summary)Prior1YTDDuration12285735000JPY
Net sales (5-year summary)CurrentYTDDuration12785442000JPY
Net sales (5-year summary)Prior1YearDuration49636012000JPY
Ordinary income loss (5-year summary)Prior1YTDDuration659791000JPY
Ordinary income loss (5-year summary)CurrentYTDDuration-63239000JPY
Ordinary income loss (5-year summary)Prior1YearDuration887467000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1YTDDuration449276000JPY
Profit loss attributable to owners of parent (5-year summary)CurrentYTDDuration-206241000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1YearDuration579604000JPY
Comprehensive income (5-year summary)Prior1YTDDuration558051000JPY
Comprehensive income (5-year summary)CurrentYTDDuration-221311000JPY
Comprehensive income (5-year summary)Prior1YearDuration783000000JPY
Net assets (5-year summary)Prior1QuarterInstant27383261000JPY
Net assets (5-year summary)CurrentQuarterInstant26505583000JPY
Net assets (5-year summary)Prior1YearInstant27068701000JPY
Total assets (5-year summary)Prior1QuarterInstant63102859000JPY
Total assets (5-year summary)CurrentQuarterInstant63588797000JPY
Total assets (5-year summary)Prior1YearInstant63551819000JPY
Basic earnings loss per share (5-year summary)Prior1YTDDuration11.26
Basic earnings loss per share (5-year summary)CurrentYTDDuration-5.24
Basic earnings loss per share (5-year summary)Prior1YearDuration14.56
Diluted earnings per share (5-year summary)Prior1YTDDuration-
Diluted earnings per share (5-year summary)CurrentYTDDuration-
Diluted earnings per share (5-year summary)Prior1YearDuration-
Equity to asset ratio (5-year summary)Prior1QuarterInstant0.434
Equity to asset ratio (5-year summary)CurrentQuarterInstant0.415
Equity to asset ratio (5-year summary)Prior1YearInstant0.425
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember40772366
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember40884504
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant40772366
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant40884504
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember719900
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesReciprocalHoldingSharesWithFullVotingRightsTreasurySharesEtcMember7300
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember39961100
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember399611
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember84066
Number of shares issued shares voting rightsCurrentQuarterInstant40772366
Number of voting rights issued shares voting rightsCurrentQuarterInstant399611
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member719900
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member-
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member719900

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-11-30pass
balance sheet identityconsolidated 2023-02-28pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-11-30pass
statement vs summary · net assetsconsolidated 2023-02-28pass
statement vs summary · net income attributable to parentconsolidated 2021-12-01/2022-02-28pass
statement vs summary · net income attributable to parentconsolidated 2022-12-01/2023-02-28pass
statement vs summary · revenueconsolidated 2021-12-01/2022-02-28pass
statement vs summary · revenueconsolidated 2022-12-01/2023-02-28pass
statement vs summary · total assetsconsolidated 2022-11-30pass
statement vs summary · total assetsconsolidated 2023-02-28pass